Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Bibliographic Details
Main Authors: Jawad, Mays, Yu, Ning, Seedhouse, Claire, Tandon, Karuna, Russell, Nigel H, Pallis, Monica
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488582/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488582/

Similar Items